Company: TVRD
Filing Date: 2025-05-30
Form Type: S-1
Source: 0001104659-25-054853
Chunk: 222

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-05-30
Form: S-1
Chunk 222
---
 or range of potential losses, if any, from this action.

128

Other Proceedings

From time to time, the Company may be subject to legal proceedings and claims arising in the ordinary course of its business. The Company is not currently a party or aware of any proceedings that it believes will have, individually or in the aggregate, a material adverse effect on the Company’s business, financial condition or results of operations.**

<div align='center'>129</div>

MANAGEMENT Executive Officers and Directors The following table sets forth the names, ages, and positions of our executive officers and members of our board of directors (the “Board”) as of April 15, 2025:

| ​                           | ​ |   ​ | ​ | ​                                                     |
| Name                        |   | Age |   | Position(s)                                           |
| Executive Officers          |   |     |   |                                                       |
| Imran Alibhai, Ph.D.        |   |  49 |   | Chief Executive Officer and Director                  |
| Dan Conn, J.D., M.B.A.      |   |  58 |   | Chief Financial Officer                               |
| John Kauh, M.D.             |   |  52 |   | Chief Medical Officer                                 |
| Jeffrey Larson, Ph.D., DABT |   |  63 |   | Senior Vice President, Research & Development         |
| Yixin “Joseph” Chen, Ph.D.  |   |  64 |   | Vice President, Chemistry, Manufacturing and Controls |
| ​                           | ​ |   ​ | ​ | ​                                                     |
| Non-Employee Directors      |   |     |   |                                                       |
| Sujal Shah                  |   |  51 |   | Chair of the Board of Directors                       |
| Wallace Hall                |   |  63 |   | Director                                              |
| Shaheen Wirk, M.D.          |   |  48 |   | Director                                              |
| Michael S. Wyzga            |   |  70 |   | Director                                              |
| Cynthia Smith               |   |  56 |   | Director                                              |
| Susan Shiff, Ph.D.          |   |  64 |   | Director                                              |

Executive Officers Imran Alibhai, Ph.D., was appointed as our Chief Executive Officer and a member of our board of directors upon the closing of the Merger. Dr. Alibhai served as Legacy Tvardi’s Chief Executive Officer and